United Kingdom· GB-APID-12684611000001108
ATryn 1,750unit powder for solution for infusion vials
A medicinal product containing antithrombin alfa, registered in United Kingdom by LEO Pharma.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Antithrombin alfa
- Manufacturer
- LEO Pharma
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 1
- gtin5702191007244
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Antithrombin alfa in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8ab641c3-b7ab-453d-8f93-110510f1929a GET /v1/drugs/8ab641c3-b7ab-453d-8f93-110510f1929a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "12684611000001108",
"desc": "ATryn 1,750unit powder for solution for infusion vials (LEO Pharma)",
"form": "Powder for solution for infusion",
"vpid": "12680711000001105",
"source": "dmd",
"vtm_id": "777408003",
"strength": "1750 unit",
"substance": "Antithrombin alfa",
"ingredient": "Antithrombin alfa",
"supplier_code": "2269001000001104"
}See everything about antithrombin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.